Lazertinib - HY-109061
Nur noch %1 verfügbar
Catalog #
HY-109061
Ab
125,00 €
Lazertinib (YH25448) is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor, and can be used in the research of non-small cell lung cancer[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-109061/Lazertinib-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Alternative Names | YH25448; GNS-1480 |
| CAS | 1903008-80-9 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 554.64 |
| Solubility | DMSO : 3.33 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | Launched |
| Target | EGFR |
| Application: | Cancer-Kinase/protease |
|---|